blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3894554

EP3894554 - CHEMICALLY-MODIFIED RNAI CONSTRUCTS AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  17.09.2021
Database last updated on 09.09.2024
FormerThe international publication has been made
Status updated on  20.06.2020
Formerunknown
Status updated on  07.01.2020
Most recent event   Tooltip19.12.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320 / US
[2021/42]
Inventor(s)01 / MURRAY, Justin K.
One Amgen Center Drive
Law Dept - Patent
Operations, M/S 28-5-A
Thousand Oaks, California 91320-1799 / US
02 / WU, Bin
One Amgen Center Drive
Law Dept - Patent
Operations, M/S 28-5-A
Thousand Oaks, California 91320-1799 / US
03 / CHENG, Yuan
One Amgen Center Drive
Law Dept - Patent
Operations, M/S 28-5-A
Thousand Oaks, California 91320-1799 / US
04 / HERBERICH, Bradley J.
One Amgen Center Drive
Law Dept - Patent
Operations, M/S 28-5-A
Thousand Oaks, California 91320-1799 / US
 [2021/42]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2021/42]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date19828505.809.12.2019
[2021/42]
WO2019US65294
Priority number, dateUS201862777677P10.12.2018         Original published format: US 201862777677 P
[2021/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020123410
Date:18.06.2020
Language:EN
[2020/25]
Type: A1 Application with search report 
No.:EP3894554
Date:20.10.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 18.06.2020 takes the place of the publication of the European patent application.
[2021/42]
Search report(s)International search report - published on:EP18.06.2020
ClassificationIPC:C12N15/11
[2021/42]
CPC:
C12N15/111 (EP,IL); C12N15/113 (KR,US); A61K31/7105 (KR);
A61K31/713 (US); A61K48/00 (KR); C12N2310/14 (EP,IL,KR,US);
C12N2310/315 (EP,IL); C12N2310/321 (EP,IL,KR,US); C12N2310/322 (EP,IL,KR,US);
C12N2310/3231 (EP,IL,KR,US); C12N2310/344 (EP,IL,KR,US); C12N2310/345 (EP,IL,KR,US);
C12N2310/346 (EP,IL,KR,US); C12N2310/351 (EP,IL,KR,US); C12N2310/3521 (EP,IL,KR,US);
C12N2310/3523 (EP,IL,KR,US); C12N2310/3525 (EP,IL,KR,US); C12N2310/3533 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/42]
TitleGerman:CHEMISCH MODIFIZIERTE RNAI-KONSTRUKTE UND DEREN VERWENDUNG[2021/42]
English:CHEMICALLY-MODIFIED RNAI CONSTRUCTS AND USES THEREOF[2021/42]
French:CONSTRUCTIONS D'ARNI MODIFIÉES ET UTILISATIONS CORRESPONDANTES[2021/42]
Entry into regional phase07.06.2021National basic fee paid 
07.06.2021Designation fee(s) paid 
07.06.2021Examination fee paid 
Examination procedure07.06.2021Examination requested  [2021/42]
07.06.2021Date on which the examining division has become responsible
26.01.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
10.11.2021Renewal fee patent year 03
20.12.2022Renewal fee patent year 04
19.12.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2013074974  (ALNYLAM PHARMACEUTICALS INC [US]);
 [A]WO2016028649  (ALNYLAM PHARMACEUTICALS INC [US]);
by applicantUS5539082
 WO9640964
 US5714331
 US5719262
 US5783565
 US5837533
 US5976567
 US5981505
 US5981501
 US6127170
 US6217900
 US6379965
 US6383512
 US6534484
 US6586410
 US2003130186
 WO03093449
 US6693187
 US6747014
 US6815432
 US7202227
 US7491805
 US7723509
 US7745608
 US7833992
 US7851615
 US8017762
 US8106022
 US8188247
 WO2013166155
 US8828956
 US8877917
 US9181551
 US2016122761
 WO2017058944
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.